Karamjeet Singh Sandhu, M.D. | City of Hope

Dr. Karamjeet Sandhu, M.D.

Claim this profile

City of Hope Medical Center

Studies Cancer
Studies Acute Myelogenous Leukemia
5 reported clinical trials
7 drugs studied

Area of expertise

1

Cancer

Karamjeet Sandhu, M.D. has run 3 trials for Cancer. Some of their research focus areas include:

HLA-A positive
HLA-A negative
HLA positive
2

Acute Myelogenous Leukemia

Karamjeet Sandhu, M.D. has run 2 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:

CD33 positive
HLA-A positive
HLA-A negative

Affiliated Hospitals

Image of trial facility.

City Of Hope Medical Center

Image of trial facility.

City Of Hope

Clinical Trials Karamjeet Sandhu, M.D. is currently running

More about Karamjeet Sandhu, M.D.

Clinical Trial Related

4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Karamjeet Sandhu, M.D. has experience with

  • Anti-CD33 CAR T-cells
  • Lymphodepletion Therapy
  • Human Lysozyme Goat Milk
  • Electron Beam Radiotherapy
  • B. Infantis (PBCLN-014)
  • Human Milk Oligosaccharides (HMO) (PBCLN-010)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Karamjeet Sandhu, M.D. specialize in?

Is Karamjeet Sandhu, M.D. currently recruiting for clinical trials?

Are there any treatments that Karamjeet Sandhu, M.D. has studied deeply?

What is the best way to schedule an appointment with Karamjeet Sandhu, M.D.?

What is the office address of Karamjeet Sandhu, M.D.?

Is there any support for travel costs?